AUSTIN, Texas — The Centers for Disease Control and Prevention says lyman-19 can be used to treat diabetes and to treat a variety of other conditions, but it has only been approved for the treatment of people with type 1 diabetes.
The FDA says that is the first time lyme has been approved to treat people with the disease.
It was also the first drug approved for treating type 1 Diabetes in the U.S.
Lyman-39 is also being tested in people with cancer.
The agency said its approval is based on a clinical trial of lyman in people in remission from cancer.
In a statement, the FDA said it will release more information on the new drug, including details on potential side effects, on Monday.